Manufacturers are still waiting for US FDA to clarify its position on off-label communications, but recent draft guidance documents provide some helpful advice.
Three experts, including an FDA official, addressed important takeaways from the two documents that were issued in the closing days of the Obama administration to outline FDA policy on industry...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?